- Home
- ANTE vs DRRX Comparison
ANTE vs DRRX Comparison
Compare ANTE & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- DRRX
- Stock Information
- Founded
- ANTE 2005
- DRRX 1998
- Country
- ANTE China
- DRRX United States
- Employees
- ANTE N/A
- DRRX N/A
- Industry
- ANTE Advertising
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- ANTE Consumer Discretionary
- DRRX Health Care
- Exchange
- ANTE Nasdaq
- DRRX Nasdaq
- Market Cap
- ANTE 70.8M
- DRRX 59.0M
- IPO Year
- ANTE N/A
- DRRX 2000
- Fundamental
- Price
- ANTE $2.70
- DRRX $1.91
- Analyst Decision
- ANTE
- DRRX Hold
- Analyst Count
- ANTE 0
- DRRX 1
- Target Price
- ANTE N/A
- DRRX N/A
- AVG Volume (30 Days)
- ANTE 315.1K
- DRRX 2.9M
- Earning Date
- ANTE 09-29-2025
- DRRX 08-12-2025
- Dividend Yield
- ANTE N/A
- DRRX N/A
- EPS Growth
- ANTE N/A
- DRRX N/A
- EPS
- ANTE N/A
- DRRX N/A
- Revenue
- ANTE $343,000.00
- DRRX $1,657,000.00
- Revenue This Year
- ANTE N/A
- DRRX N/A
- Revenue Next Year
- ANTE N/A
- DRRX $673.00
- P/E Ratio
- ANTE N/A
- DRRX N/A
- Revenue Growth
- ANTE N/A
- DRRX N/A
- 52 Week Low
- ANTE $0.26
- DRRX $0.48
- 52 Week High
- ANTE $3.67
- DRRX $2.64
- Technical
- Relative Strength Index (RSI)
- ANTE 59.92
- DRRX 84.64
- Support Level
- ANTE $1.95
- DRRX $1.85
- Resistance Level
- ANTE $2.94
- DRRX $1.92
- Average True Range (ATR)
- ANTE 0.55
- DRRX 0.09
- MACD
- ANTE 0.02
- DRRX 0.01
- Stochastic Oscillator
- ANTE 61.96
- DRRX 10.98
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.